In future investigations, we intend to identify whether IL-17A expression in glioma is solely a CD4+ T cell cytokine or if B cells also produce this cytokine through analysis of IL-17A mRNA levels in CD4 T cell- and B cell-deficient mice with malignant glioma. Here, IL17A is linked to central nervous system cancer.